Originally published In Press as doi:10.1074/jbc.M000547200 on May 23, 2000
J. Biol. Chem., Vol. 275, Issue 33, 25073-25081, August 18, 2000
Thermogenic Responses in Brown Fat Cells Are Fully
UCP1-dependent
UCP2 OR UCP3 DO NOT SUBSTITUTE FOR UCP1 IN ADRENERGICALLY OR
FATTY ACID-INDUCED THERMOGENESIS*
Anita
Matthias
,
Kerstin B. E.
Ohlson,
J. Magnus
Fredriksson,
Anders
Jacobsson,
Jan
Nedergaard§, and
Barbara
Cannon§
From the Wenner-Gren Institute, The Arrhenius Laboratories F3,
Stockholm University, SE-106 91 Stockholm, Sweden
Received for publication, January 24, 2000, and in revised form, May 8, 2000
 |
ABSTRACT |
To examine the thermogenic significance of the
classical uncoupling protein-1 (UCP1), the thermogenic potential of
brown adipocytes isolated from UCP1-ablated mice was investigated.
Ucp1(
/
) cells had a basal metabolic rate identical to
wild-type; the mitochondria within them were coupled to the same
degree. The response to norepinephrine in wild-type cells was robust
(
10-fold increase in thermogenesis); Ucp1(
/
) cells only responded
3% of
this. Ucp1(
/
) cells were as potent as
wild-type in norepinephrine-induced cAMP accumulation and lipolysis and
had a similar mitochondrial respiratory complement. In wild-type cells,
fatty acids induced a thermogenic response similar to norepinephrine,
but fatty acids (and retinoate) were practically without effect in
Ucp1(
/
) cells. It is concluded that no
other adrenergically induced thermogenic mechanism exists in brown
adipocytes except that mediated by UCP1 and that entopic expression of
UCP1 does not lead to overt innate uncoupling, and it is suggested that
fatty acids are transformed to an intracellular physiological activator
of UCP1. High expression of UCP2 and UCP3 in the tissue was not
associated with an overt innate highly uncoupled state of mitochondria
within the cells, nor with an ability of norepinephrine or endo- or
exogenous fatty acids to induce uncoupled respiration in the cells.
Thus, UCP1 remains the only physiologically potent thermogenic
uncoupling protein in these cells.
 |
INTRODUCTION |
The thermogenic capacity of brown adipocytes is unsurpassed in
mammalian tissues; after the addition of the physiological stimulator
norepinephrine, brown adipocytes can chronically increase their
metabolism 10-fold (1, 2) and produce heat at a rate of about 3 nanowatts/cell, corresponding to about 300 watts/kilogram of
tissue (3, 4). The biochemical mechanism behind this remarkable
metabolic achievement has attracted scientific interest since the
heat-producing capacity of brown adipose tissue was first established
(5). It is today generally accepted that the heat-producing ability of
brown adipocytes is fully or partly a consequence of the presence in
the mitochondria of these cells of the functionally protonophoric
protein uncoupling protein-1 (UCP1)1 (thermogenin) (for
reviews, see Refs. 6-9).
However, it is first with the development of UCP1-ablated mice in the
laboratory of L. P. Kozak (10) that it has become possible to
approach some basic questions in the cellular physiology of brown
adipocytes. These questions include whether the UCP1 mechanism is the
only thermogenic mechanism of significance within the brown adipocytes
and whether the mere presence of UCP1 within the brown adipocytes in
itself conveys a state of semi-uncoupling to the mitochondria within
the cells (as has been observed when UCP1 has been ectopically
expressed (11-14)). Also the question of the nature of the
intracellular physiological activator of UCP1 has become timely,
because it has been observed that the presence of UCP1 in isolated
brown fat mitochondria does not seem to increase their sensitivity to
the de-energizing action of fatty acids (15), although fatty acids have
generally been believed to be the activators of UCP1 (6-9). Through
analysis of brown adipocytes isolated from UCP1-ablated mice, we
present evidence here that no other adrenergic thermogenic mechanism
exists in brown adipocytes except that associated with UCP1, and that
UCP1 in its unstimulated state, when entopically expressed and under physiological control, does not induce a state of partial
"uncoupling" to the mitochondria, at least not observable at the
present degree of resolution. We also suggest that the activator of
UCP1 is most likely not the free fatty acids themselves but a
metabolite thereof.
Further, brown adipose tissue in the UCP1-ablated mice demonstrates
very high expression levels of the UCP1 family members UCP2 and UCP3
(10, 15, 16), probably the highest combined level in any mammalian
tissue. It has therefore been possible to analyze the
Ucp1(
/
) brown adipocytes also for signs of
thermogenic (or uncoupling) effects that could be associated
with the very high entopic expression of the genes for these novel
uncoupling proteins, as suggested (17). We found, however, that this
high entopic expression was not associated with any observable signs of
mitochondrial uncoupling or thermogenesis, in contrast to what is
observed when these proteins have been ectopically expressed. Thus,
UCP2 or UCP3 do not substitute for UCP1 as adrenergically stimulated
thermogenic proteins in brown adipocytes, even when the cellular
activation mechanism for thermogenesis is intact. We therefore
conclude that UCP1 distinguishes itself from the other (probably more
ancient (18)) uncoupling protein family members by being the only one
that can convey to a mammalian cell a thermogenic response to
adrenergic stimulation.
 |
MATERIALS AND METHODS |
Animals--
The UCP1-ablated mice were progeny of those
described by Enerbäck et al. (10) in which the gene
coding for UCP1 was inactivated by homologous recombination with a
deletion vector in which exon 2 and parts of exon 3 had been replaced
with a neomycin resistance gene; in the brown fat of these mice, no
UCP1 can be detected with polyclonal antibodies
(10).2 The mice were bred at
the institute. The wild-typemice used were of the C57BL/6
strain (i.e. the blastocyst donor strain for the gene
ablation (10)) and were obtained from B&K Universal, Stockholm, Sweden.
Before the experiments, adult (8-10 weeks old) female mice of either
strain were acclimated to 24 °C (12 h light, 12 h dark) for at
least 3 weeks with free access to food and water.
Cells--
Mouse brown adipocytes were isolated (19) as earlier
described by collagenase digestion of pooled brown adipose tissue
depots (4, 20) with some modifications. Routinely, on each experimental day, 6-8 wild-type and/or 5 UCP1-ablated mice were killed by
CO2 anesthesia and decapitated. The interscapular,
cervical, and axillary brown adipose tissue depots were cleaned from
contaminating muscle and white adipose tissue and put into Krebs-Ringer
phosphate buffer containing 4% crude bovine serum albumin (see
"Buffers"). This buffer was changed to 3 ml with 1.3 mg/ml
collagenase II (Sigma), and the tissue was incubated in a slowly
shaking water bath at 37 °C with vortexing every second min. After 7 min, the buffer was discarded, and the tissue was placed in 6 ml of
fresh buffer with 0.67 mg/ml collagenase II, minced with scissors, and
incubated for 45 min in the water bath, vortexing every 5 min. The
buffer with cells and tissue fragments was filtered through silk cloth, and the filtrate, containing the adipocytes, was centrifuged for 8 min
at
30 × g. The infranatant was discarded and fresh
buffer was added. The remaining tissue was incubated another 30-45 min in 3 ml of buffer with 0.33 mg/ml collagenase, vortexed every 5 min,
and collected. The two cell suspensions were pooled and washed by
floating for 1 h. The buffer was removed, and the concentrated cell suspension, 1-4 × 106 cells/ml, was routinely
kept at room temperature during the day of the experiment. The cells
were counted in a Bürker chamber. Samples with the intended
amount of cells for each experiment were taken from the concentrated
cell suspension. The yield of cells from the wild-type mice averaged
5.5 × 106 cells/preparation and that from the
UCP1-ablated mice was 7 × 106.
Oxygen Consumption--
Oxygen consumption rates of the isolated
brown adipocytes were monitored with a Clark-type oxygen electrode, as
described previously (21). About 100,000 cells (for certain experiments with UCP1-ablated mice up to 200,000 cells) were added to a
magnetically stirred oxygen electrode chamber thermostated to 37 °C,
containing Krebs-Ringer bicarbonate buffer (see "Buffers") to a
final volume of 1.1 ml. The chamber was closed, and the cells were
incubated for
4 min to determine the basal respiratory rate.
Additions were then made with a Hamilton syringe through a small hole
in the cover of the chamber. The output signal from the oxygen
electrode amplifier (proportional to the oxygen tension) was
electronically time-differentiated as described (22). The
time-differentiated signal (proportional to the oxygen consumption
rate) was collected every 0.5 s by a MacLab/2e (application
program Chart v3.5). The MacLab Chart data files were transferred to
the KaleidaGraph Macintosh application. After conversion of the data
files to absolute values (based on an oxygen content of 217 nmol of
O2/ml of water, on the calibrated electronic differentiator
constants, and on the cell number used), the data files were used to
calculate running means and standard errors. For calculation of stable
oxygen consumption rates, mean values during about 1 min were obtained
from these recordings.
Cyclic-AMP Determination--
~200,000 cells/ml from each type
of preparation were preincubated for 10 min in a shaking water bath at
37 °C in the Krebs-Ringer bicarbonate buffer detailed under
"Buffers." After the preincubation, zero time samples of 500 µl
were taken, and 1 µM norepinephrine (or water) was added.
New samples were taken 2 min after these additions. Samples were dried
in a SpeedVac centrifuge, and the pellets were suspended in 1 ml of
4 × Tris-EDTA buffer and sonicated for 5 s. After
centrifugation, a 50-µl supernatant aliquot was collected for
analysis with the cyclic AMP assay system (Amersham Pharmacia
Biotech), according to the manufacturer's instructions. cAMP
accumulation was defined as the difference between the 2 min and the
zero time samples.
Lipolysis--
Brown adipocytes (about 200,000 cells/ml) were
incubated in Krebs-Ringer bicarbonate buffer at 37 °C in a shaking
water bath. At zero time, 500-µl aliquots were taken, and 1 µM norepinephrine (or water) was added. Ten min later,
another 500-µl sample was taken. The samples were frozen. The thawed
samples were deproteinated with 31% perchloric acid and
neutralized with 5 M K2CO3. After centrifugation for 10 min at 3000 × g, the
supernatants were used to determine glycerol with the Biochemical
Analysis and Food Analysis kit for glycerol from Roche Molecular
Biochemicals. Glycerol release was defined as the difference
between the 10 min and the zero time samples.
Buffers--
Krebs-Ringer phosphate buffer (used for cell
preparation and storage only) had the following composition: 148 mM Na+, 6.9 mM
K+, 1.5 mM Ca2+, 1.4 mM Mg2+, 119 mM Cl
,
1.4 mM SO 42
, 5.6 mM H2PO
4
, 16.7 mM HPO42
, 10 mM glucose, 10 mM fructose, with 4% crude
bovine serum albumin. The pH was adjusted with Tris-OH to 7.4. Krebs-Ringer bicarbonate buffer (used for all cellular experiments) had
the following composition: 145 mM Na+, 6.0 mM K+, 2.5 mM Ca2+, 1.2 mM Mg2+, 128 mM Cl
,
1.2 mM SO 42
, 25.3 mM HCO 3
, 1.2 mM H2PO4
, 10 mM glucose, 10 mM fructose, with 4%
fatty-acid-free bovine serum albumin. This buffer was purchased as a
sterile solution from SVA, Uppsala, Sweden. The buffer was bubbled with
5% CO2 in air, and the pH was adjusted with HCl to 7.4;
the buffer was continuously bubbled at 37 °C with a small stream of
5% CO2 in air until use.
Other Materials--
Norepinephrine (Sigma) was dissolved and
diluted in water freshly prepared for each experiment. FCCP (Sigma) was
dissolved in 95% ethanol and pyruvate and methyl pyruvate (Sigma) in
water. Oleate (sodium salt, Sigma) was dissolved in and diluted in
ethanol:water, 2:1. Laurate (lauric acid (Schuchardt), all-trans
retinoic acid (Sigma) and TTNPB
(4-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid) (Tocris)) were dissolved and diluted in
Me2SO.
 |
RESULTS |
Norepinephrine Stimulation of Respiration in Brown Fat Cells Is
Entirely UCP1-dependent--
The thermogenic capacity of
brown adipose tissue is reflected in the ability of isolated brown
adipocytes to respond to addition of the sympathetic neurotransmitter
norepinephrine with an extremely large increase in oxygen
consumption (thermogenesis) (1-4, 19, 23, 24).
This dramatic thermogenic response was also observable in the brown
adipocytes isolated here from wild-type mice. Thus, as seen in Fig.
1A, wt curve, the
basal respiration of the brown adipocytes was very low. However,
norepinephrine addition led to a rapid and very marked increase in
oxygen consumption (thermogenesis). The magnitude of the response to
norepinephrine (
300 fmol of O2/min/cell) was similar to
that previously reported for brown adipocytes from mice (19). When
oxygen supply in the electrode chamber is not limiting, this
large thermogenic response is maintained for a prolonged time (3,
25).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of norepinephrine on respiration in
isolated mature brown adipocytes from wild-type and UCP1-ablated
mice. A, brown adipocytes were isolated in parallel
from wild-type and UCP1-ablated mice and their respiratory
(thermogenic) activity was monitored in an oxygen electrode chamber.
~100,000 cells were incubated/ml of Krebs-Ringer bicarbonate buffer
at 37 °C, as described under "Materials and Methods." At the
arrow, 1 µM norepinephrine (NE) was
added. The polarographic output was time-differentiated, sampled, and
recalculated per cell, and the data from independent preparations were
combined. Traces are running mean ± S.E. from five cell
preparations from each type of animal, isolated and studied in
parallel. B, detailed analysis of the response to
norepinephrine in brown adipocytes from UCP1-ablated mice. Experiments
were performed as in A but only in brown adipocytes from
UCP1-ablated mice and at a higher density (200,000/ml). Traces with
norepinephrine addition, alternating with vehicle (water) addition,
were collected, and the respective mean curves were constructed and the
running difference between these mean curves was calculated
(norepinephrine minus vehicle). Thus, the data represent the mean
difference ( ) between these mean traces (each based on three
experiments). Note that compared with A, the y
axis is enlarged and the x axis is
compressed.
|
|
Brown adipocytes could also be successfully isolated from the brown
adipose tissue of the UCP1-ablated animals. This was possible without
modification of the method for the wild-type cells. The yield of cells
was somewhat higher than for the wild-type animals, and the cells
appeared to be somewhat more robust. The brown adipocytes from the
UCP1-ablated mice also demonstrated a very low basal thermogenic rate.
Statistically, the rate was not different from that of the wild-type
cells (Fig. 1A) (56 ± 9 fmol O2/min/cell in wild-type and 61 ± 6 in Ucp1(
/
)
cells; mean of eight cell preparations of each type, measured in two to
six experiments in each preparation). Norepinephrine addition to the
brown adipocytes from the UCP1-ablated mice did not lead to any
increase in oxygen consumption rate, at least not an increase
discernible within the resolution of Fig. 1A. Higher doses
of norepinephrine also failed to induce thermogenesis (not shown).
In experiments designed to examine very minor effects of
norepinephrine, a very slight response was resolvable (Fig.
1B). In the calculated mean difference trace in Fig.
1B, a response to norepinephrine with a maximal magnitude of
10 fmol of O2/min/cell was observable. This response was
thus maximally only about 3% of the response in the wild-type and was
markedly transient; the basal rate was reestablished within some
minutes. Because of the transient characteristics and the limited
magnitude of this slight response, its nature escaped further
experimental scrutiny.
Taken together, these basic results experimentally established for the
first time that the presence of UCP1 is essential for the ability of
brown adipocytes to respond to norepinephrine stimulation with a
competent thermogenic response. No alternative norepinephrine-induced thermogenic mechanism, mitochondrial or nonmitochondrial, existed within the brown fat cells.
Coupling State of Mitochondria within Brown
Adipocytes--
Information on the innate coupling state of the
mitochondria within the brown adipocytes can, for example, be obtained
from the respiratory rate of the unstimulated cells. This rate was, as
indicated above, very low. Two explanations for such a low rate,
are possible: the mitochondria may lack sufficient respiratory substrate such that substrate supply limits respiratory rate, or
substrate supply may be adequate but the respiratory rate may be
limited by low proton flux through the mitochondrial membrane.
To distinguish between these two possibilities, a metabolizable
exogenous substrate may be added, i.e. a substrate that is able to enter the cells and the mitochondria. Based on earlier experiments, pyruvate is expected to fulfill this demand (4, 26-28).
If respiration is substrate-limited, the addition of pyruvate should
therefore in itself accelerate basal respiration. However, as seen in
Fig. 2A (first
arrow), the addition of pyruvate to nonstimulated wild-type cells
failed in itself to induce any increase in respiration. A similar
absence of effect was observed in Ucp1(
/
) cells (Fig. 2B). The addition of methyl pyruvate (which in
certain systems is used as a more permeant substrate) was also without effect in both cell types (not shown). Thus, in neither cell type was
there any indication that the low respiration was because of the lack
of substrate; rather, it must be a result of limiting proton flux.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of the mitochondrial uncoupler FCCP on
respiratory rate in brown adipocytes from (A)
wild-type or (B) UCP1-ablated mice. Experiments
were performed principally as in Fig. 1, except that 10 mM
pyruvate and 40 µM FCCP were added where indicated.
Curves are means from two independent cell preparations, each examined
in three experiments.
|
|
Therefore, subsequently, the effect of the mitochondrial uncoupler FCCP
was examined. Basically, a stimulatory effect of FCCP indicates that
the mitochondria within the cells are in a coupled state. Such a
stimulatory effect was clearly observed in wild-type cells (Fig.
2A, second addition) (as earlier observed in brown fat cells
from other species (25, 26)). However, the respiratory rate achieved
after FCCP alone (i.e. with an unknown endogenous substrate)
was much lower than that after the norepinephrine addition (Fig.
1A). The low relative effect of FCCP in these unstimulated cells (less than a doubling of respiratory rate) should therefore not
be interpreted as indicating that the mitochondria within the cells
were innately (i.e. before FCCP addition) in a "poorly coupled" state; rather, it is clear that it is the oxidative capacity for the unknown endogenous substrate that is limiting. This becomes even more evident when FCCP was added after the provision of exogenous substrate, pyruvate (Fig. 2A). Although this extra
substrate, as already pointed out, does not increase basal respiration,
its presence markedly increases "uncoupled" respiration. Therefore, in general, it is the ratio between the basal respiration (which is not
substrate-limited) and that in the presence of an optimal respiratory
substrate (which here is that after norepinephrine stimulation;
exogenous pyruvate is good but not optimal) that gives the most
relevant estimate of the degree of coupling. This ratio is thus about
1:10 (Fig. 1A), i.e. similar to what is observed in isolated mitochondria with an optimal thermogenic substrate (i.e. acyl carnitine) (29).
The effect of FCCP in itself was identical in the brown adipocytes from
UCP1-ablated mice (Fig. 2B, right arrow (no
pyruvate)). Thus, although a maximal level of respiration on optimal
substrate could not directly be obtained in these cells as an effect of norepinephrine stimulation (Fig. 1) (but cf. Fig. 4), it was
clear that also the mitochondria within the
Ucp1(
/
) cells were coupled (since FCCP had an
effect), and that the basal proton conductance of the mitochondria was
identical to that of the wild-type cells (as the basal rate of
respiration was the same). It was also clear that the provision of
extra substrate, i.e. pyruvate, even in these cells, further
enhanced the metabolic rate after FCCP (Fig. 2B).
As in both wild-type and Ucp1(
/
) cells, the
response to FCCP was augmented (
doubled) when pyruvate was present
(Fig. 2, A and B), pyruvate evidently also in
these cells fulfilled the criteria for being a competent exogenous
substrate (whereas methyl pyruvate did not lead to an enhanced response
to FCCP and therefore in these cells was not a competent substrate (not shown)).
Thus, as the basal thermogenic rate was low and not substrate-limited
in either cell type and as the effect of FCCP was identical in the two
cell types, the conclusion is that the coupling state of the
mitochondria within the two cells types was identical; i.e.
in the nonstimulated state, the presence of UCP1 in the mitochondria of
the wild-type cells is not associated with a high innate proton permeability. This conclusion is not directly parallel to that which
has been reached when uncoupling protein(s) are ectopically expressed
in e.g. yeast cells (see "Discussion").
Lack of Thermogenic Potency Is Not Secondary to a Defective
Adrenergic Response or Diminished Oxidative Capacity--
Although the
absence of effect of norepinephrine on thermogenesis in the cells from
the UCP1-ablated mice (Fig. 1) may adequately be understood as being a
consequence of the inability of these cells to respond to
norepinephrine by an increased mitochondrial proton permeability
(because of the absence of UCP1), it may be contended that in a more
general way the gene ablation could have altered the ability of the
brown adipocytes to respond to norepinephrine. Therefore we examined
the competence of several steps along the adrenergic response pathway
of the cells.
As the thermogenic response to norepinephrine is mainly mediated via
-adrenoreceptors (4, 23, 30, 31), we examined whether adrenergic
stimulation led to a competent second messenger response,
i.e. to an increase in cAMP levels. As expected, cAMP levels
were markedly elevated in norepinephrine-treated cells from wild-type
animals (Fig. 3A), to an
extent very similar to that seen earlier in e.g. hamster
brown adipocytes (30, 32). In the Ucp1(
/
)
cells, cAMP levels were also markedly increased, and there was no
significant difference between the cell types. Thus, intracellular
signal transduction from the
-adrenergic receptors was normal in the
brown adipocytes from UCP1-ablated mice.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Competent adrenergic responses in brown
adipocytes from UCP1-ablated mice. A, cAMP
accumulation. Cells were incubated at 37 °C in a Krebs-Ringer
bicarbonate buffer and cAMP levels determined and calculated as
described under "Materials and Methods." Values are means ± S.E. from four experimental series. The values in unstimulated (0)
cells were not significantly different from zero but in
norepinephrine-stimulated brown adipocytes from both wild-type
(wt) and UCP1-ablated (Ucp1( / ))
mice, a statistically significant (*, p < 0.05;
student's paired t test) increase in cAMP was observed.
There was no significant difference between the increase in the two
cell types. B, glycerol release. Cells were incubated at
37 °C in Krebs-Ringer bicarbonate buffer and glycerol levels were
determined and calculated as described under "Materials and
Methods." Values are mean ± S.E. from three to four
experimental series. The values in unstimulated (0) cells were not
significantly different from zero but in norepinephrine-stimulated
brown adipocytes from both wild-type (wt) and UCP1-ablated
(Ucp1( / )) mice, a statistically significant
(*, p < 0.05; Student's paired t test)
increase in glycerol was observed. There was no significant difference
between the increase in the two cell types.
|
|
The action of norepinephrine in bringing about thermogenesis also
involves provision of substrate for combustion (and probably also of a
UCP1 activator, see "Discussion"). This occurs by activation of
lipolysis presumably through protein kinase A-mediated phosphorylation of hormone-sensitive lipase (33) and subsequent breakdown of the stored
triglycerides to fatty acids and glycerol. We examined lipolysis as the
rate of glycerol release. As seen in Fig. 3B, no detectable
release of glycerol from the cells occurred in the absence of
adrenergic stimulation. Norepinephrine stimulated glycerol release in
wild-type cells, as earlier demonstrated (25). Norepinephrine also
stimulated lipolysis in the Ucp1(
/
) cells, to
at least the same extent as in the cells from the wild-type animals.
Thus, the absence of a marked thermogenic response in the cells from the UCP1-ablated animals was not because of an inability of
norepinephrine to stimulate lipolysis, and thus fatty acid release, in
these cells.
The result of this lipolysis should be that even in the
Ucp1(
/
) cells, endogenous substrate (fatty
acids) was provided during norepinephrine stimulation but that it could
not be combusted because of an inability to activate a mitochondrial
uncoupling process. To examine the possibility that noncombusted
substrate accumulated in the Ucp1(
/
) cells
during norepinephrine stimulation, we examined the effect of the
mitochondrial uncoupler FCCP added after norepinephrine stimulation. In
wild-type cells (Fig. 4A), the
large norepinephrine-induced thermogenesis could only be marginally increased by FCCP, indicating that the mitochondria within these cells
were practically fully uncoupled because of norepinephrine stimulation
(principally as earlier observed in brown fat cells from other species
(26)). In the Ucp1(
/
) cells, the picture was
very different (Fig. 4B). Again, norepinephrine had
practically no effect, but when FCCP was added after norepinephrine, an
enhanced effect of FCCP was seen, both as compared with that observed
in wild-type cells (Fig. 4A) and as compared with what was
seen when FCCP was added to unstimulated
Ucp1(
/
) cells (Fig. 4B). From this, it can be concluded that in the Ucp1(
/
)
cells, the addition of norepinephrine had provided substrate but did
not activate uncoupling. Further, the large thermogenic response
observed confirms that the low response to norepinephrine in these
cells was not because of a lack of respiratory capacity but was indeed
only a reflection of a lack of inducible uncoupling.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of artificial uncoupling after
adrenergic stimulation in wild-type and
Ucp1( / ) brown
fat cells. Cells were incubated principally as in Fig. 1 but after
norepinephrine (NE) or water addition, 40 µM
FCCP was added. B is the running mean of three traces.
|
|
Free Fatty Acids Mimic Norepinephrine Activation of UCP1--
In
classical observations on the effects of norepinephrine on isolated
brown adipocytes (1, 34-36), the remarkable observation was made that
the thermogenesis-inducing effect of norepinephrine could be
experimentally mimicked by the addition of free fatty acids to the
cells. Until now, two interpretations of this type of observation have
been possible. One interpretation is that what is seen is simply a
reflection of a general uncoupling effect of fatty acids, observable in
mitochondria from any tissue (37, 38). Indeed, that fatty acids may
stimulate respiration not only in isolated mitochondria but also in
several cell types has recurrently been established (39). The notably
high response in brown adipocytes could therefore be merely a
reflection of this general uncoupling effect in combination with a high
general respiratory capacity of the mitochondria of these cells and
especially of their high competence for fatty acid catabolism. The
alternative interpretation is that the thermogenic effect of fatty acid
addition is a specific effect of activation of UCP1 (with the fatty
acids also being substrate for the induced respiration) and that the thermogenic effect therefore may be interpreted to resemble the physiological activation process of UCP1. With the availability of
cells from the UCP1-ablated mice, it has become possible to conclude on
this classical question in the cellular physiology of brown adipose tissue.
In agreement with the result of earlier studies in brown fat cells from
other species (1, 34-36), the addition of a free fatty acid (here
oleate) to cells from wild-type mice resulted in a marked stimulation
of respiration (Fig. 5A). The
maximal respiration reached even exceeded that following norepinephrine stimulation and the kinetics were much faster (cf. Fig.
1A); for both norepinephrine- and oleate-induced
respiration, the kinetics could adequately be described as a simple
exponential function of time (not shown), but the half-time was 28 s following norepinephrine addition and as short as 12 s after
oleate addition.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of oleate on respiration in isolated
mature brown adipocytes from wild-type and
Ucp1( / )
mice. Experiments were performed principally as
in Fig. 1, except that 5 mM oleate was added as indicated.
A, traces are means ± S.E. from five cell preparations
from each type of animal, isolated and studied in parallel.
B, detailed analysis of the response to oleate in brown
adipocytes from UCP1-ablated mice. Experiments were analyzed as
described in Fig. 1B.
|
|
In contrast, when oleate was added to brown adipocytes from the
UCP1-ablated mice, respiration was barely stimulated (Fig. 5A). Only in experiments designed to examine very minor
effects of oleate was a small and transient response resolvable (Fig. 5B). This response was in the order of 30 fmol
O2/min/cell, i.e. about 8% of the wild-type
response. That the ability of free fatty acids to elicit thermogenesis
had been lost in these cells allows the conclusion to be drawn for the
first time that added fatty acids induce respiration in the cells from
wild-type mice as a result of activation of UCP1.
That the inability of exogenous fatty acids to induce thermogenesis was
not because of a limitation in the ability of the Ucp1(
/
) cells to catabolize them is
visualized in Fig. 6A. As seen, when a fatty acid (here laurate) was added to wild-type cells, a
high level of respiration (thermogenesis) was again directly induced,
and an artificial uncoupler had no marked further effect, indicating
that the mitochondria were fully uncoupled. When the fatty acid
(laurate) was added to Ucp1(
/
) cells, it had
again in itself no thermogenic effect, but a high thermogenic rate was induced with FCCP, showing that the cells were clearly fully
catabolically competent also with exogenous fatty acids but that fatty
acid addition did not induce any unspecific uncoupling.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of laurate and retinoate on
respiration in isolated mature brown adipocytes from wild-type and
Ucp1( / )
mice. Experiments were performed principally as
in Fig. 1, except that in A, 5 mM laurate
(dissolved in Me2SO) was added and in B,
1 mM retinoic acid (in Me2SO).
|
|
Thus, fatty acids were only able to induce uncoupling in
UCP1-containing cells. The notable divergence in this respect of these
cellular results from those obtained with isolated brown fat
mitochondria (15) is elaborated on under "Discussion."
The fatty acid-like retinoic acid has been suggested to be an activator
of UCP1 (40). This was confirmed in Fig. 6C, as retinoic
acid was able to activate thermogenesis in UCP1-containing cells. At
the same concentration, retinoic acid had no effect in the
Ucp1(
/
) cells, nor had the analogue TTNPB
(not shown). Thus, at this concentration, retinoic acid and its
analogue were unable to activate thermogenesis through any non-UCP1
proteins present in the mitochondria and could not be transformed into such an activator by any cellular processes.
 |
DISCUSSION |
In the present investigation, we have demonstrated that the
absence of UCP1 led to a complete loss of thermogenic capacity of
isolated brown fat cells, both when they were stimulated by addition of
the physiological activator norepinephrine and when thermogenesis was
induced by fatty acid addition. Besides demonstrating the
essential role of UCP1 for nonshivering thermogenesis in brown fat
cells, these experiments also provide new information on the basal and
stimulated activity of UCP1 when entopically expressed and information
concerning the nature of the intracellular physiological activator of
UCP1. They also indicate that UCP2 and UCP3 do not substitute for UCP1
as thermogenic proteins in these cells.
No UCP1-independent Adrenergic Thermogenic Process Exists in Brown
Adipocytes--
From previous studies, particularly in isolated brown
fat mitochondria (reviewed e.g. in Refs. 6-9), it has been
inferred that activation of UCP1 is a prerequisite for thermogenesis.
Provided that this axiom, that brown fat thermogenesis occurs only
through the UCP1-mediated mechanism, is accepted per se, the
outcome of the present experiments, i.e. that it is not
possible to elicit thermogenesis in brown fat cells from the
UCP1-ablated mice, may be said to be what would be expected. However,
it may be pointed out that this total elimination of the thermogenic
response to norepinephrine in the Ucp1(
/
)
cells finally resolves experimentally the long standing principal issue
of whether other mechanisms could be responsible for, or at least
contribute to, the thermogenic response to norepinephrine in brown fat
cells. Possible extramitochondrial thermogenic processes that have been
discussed include norepinephrine-induced activation of the plasma
membrane Na+/K+-ATPase (directly or indirectly
because of norepinephrine-induced plasma membrane depolarization
and increased Na+ influx), an ATP-utilizing substrate
cycling (of fatty acids/triglyceride or glucose/glucose
6-phosphate), glycerol 3-phosphate cycling, peroxisomal fatty
acid degradation, and an
1-adrenoreceptor-induced, "coupled" respiration.
It is the clear outcome of the present experiments that no such
additional UCP1-independent adrenergic thermogenic component exists
(although auxillary effects of these processes cannot be ruled out by
the present experiments). Other cellular processes clearly make only an
extremely minor contribution to norepinephrine-induced thermogenesis,
as compared with that of UCP1. Considering the number of metabolic
processes not supposedly linked to UCP1 activation that are stimulated
by norepinephrine in these cells (e.g. ion fluxes), it is
indeed remarkable that there is only such a small norepinephrine-induced UCP1-independent increase in oxygen consumption.
When Entopically Expressed, UCP1 Is Not Innately an Overtly Active
Mitochondrial De-energizer--
It is clear from the present
experiments that the entopic expression of UCP1 in the mitochondria
within brown fat cells does not lead to a measurable increase in basal
metabolism of these cells. In other words, the large proton
(equivalent)-conducting activity of UCP1 does not manifest itself
unless the cells are externally stimulated, physiologically or with
fatty acids. The low respiratory rate in unstimulated cells is not
because of a lack of substrate, as the addition of the adequate
exogenous substrate pyruvate addition is without effect and as FCCP
increases the respiratory rate even in UCP1-containing cells.
The lack of overt innate uncoupling activity of UCP1 in situ
implies that when brown fat-derived nonshivering thermogenesis is not
needed, there is no leakage through the system and thus no waste of
energy. It will be noted that in this respect the behavior of UCP1 when
entopically expressed is in contrast to its properties when it is
ectopically expressed in yeast cells (or in HeLa cells (41)). Indeed,
when UCP1 is expressed in certain yeast strains, these strains have
decreased viability and growth rate (11, 12, 42) (although not all
authors report this (43, 44)). This loss of viability, associated with
a marked decrease in mitochondrial membrane potential as estimated
within the yeast cells (11-14), has been interpreted to indicate that in these yeast cells, UCP1 is functionally correctly inserted in the
mitochondria. However, the present experiments demonstrate that this
type of high innate uncoupling is not a property of UCP1 when it is
entopically expressed. Rather, when UCP1 is functionally correctly
inserted in its native environment, no overt innate uncoupling effect
is expected. Why UCP1 behaves differently in this respect when
entopically and ectopically expressed is not known. One possibility
would be that brown fat cells possess an endogenous inhibitor of UCP1
activity unique to these cells; another possibility would be that the
yeast expression is so high that the normal functioning of the
mitochondria is disturbed.
The Nature of the Intracellular Physiological Activator--
In
this investigation, the presence of UCP1 has been demonstrated to be
essential not only for norepinephrine to elicit thermogenesis but also
for added fatty acids to accomplish this. In this respect, the present
results may initially be considered to be discrepant with our earlier
observations in isolated brown fat mitochondria, where the uncoupling
effect of fatty acids was demonstrated not to be
UCP1-dependent (15). However, the mitochondrial and
cellular observations may rather be analyzed together, as done below,
and through this may bring further insight to a basic question in the cellular physiology of brown adipose tissue: the nature of the
signaling process leading from adrenergic receptor activation to acute
UCP1 activation.
There are a number of suggestions in the literature as to the nature of
this "intracellular physiological activator." Some of the
candidates for the activator are summarized in Fig.
7.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
The nature of intracellular physiological
activator; suggested pathways for UCP1 activation within brown fat
cells. Models A-D are described in more detail under
"Discussion." The present data are in themselves consistent
with models A, C, and D, but in
connection with earlier results, we consider model D to be
the most likely. NE, norepinephrine; TG,
triglyceride; FFA, free fatty acids; ,
-oxidation etc.; IPA, intracellular physiological
activator.
|
|
One model (Fig. 7A) distinguishes itself from models
B-D in that the state of UCP1 in the unstimulated cell is differently formulated. According to this hypothesis, it is visualized that UCP1 is
innately in an uninhibited state because it is considered not to be
exposed to purine nucleotides (that inhibit UCP1 activity in
experiments performed with isolated brown fat mitochondria and with
isolated UCP1, as reviewed in e.g. Refs. 6 and 7). In this
hypothesis, the activator may be suggested to be free fatty acids (this
suggestion is based on the necessity of fatty acids for UCP1
functioning in ectopic and reconstituted system; however, it will be
remembered that added fatty acids are apparently not necessary for UCP1
to function in situ, i.e. in isolated brown fat
mitochondria (15)). Thus, in unstimulated cells, there should be so
little fatty acid available (that functions in this formulation as a
co-factor) that UCP1 is unfunctional even though it is uninhibited. During stimulation, lipolysis leads to increased fatty acid levels and
these, in this model, are the co-factors necessary to make UCP1
functional. Based on the data presented here alone, this model cannot
be refuted, but the premises for this supposition may be challenged.
The inhibitory so-called GDP-binding site on UCP1 has an affinity for
free purine nucleotides of about 1 µM (45, 46). The total
concentration of purine di- and triphosphate nucleotides in the cytosol
is probably in the order of millimolar, but the free concentrations are
lower because of the presence of Mg2+-chelated forms that
are unable to inhibit UCP1 (46). However, if about equimolar
concentrations of Mg2+ and purine nucleotides are found in
the cytosol, about 2-4% of total purine nucleotide would be in the
free form (according to Ref. 47), corresponding to some 50-100
µM free nucleotide, i.e. a concentration
widely in excess of that needed for full UCP1 inhibition. It is
therefore difficult to see how UCP1 could be in an uninhibited state
within the cell. It is also notable that in this hypothesis, the
GDP-binding site on UCP1 is devoid of any regulatory role in
thermogenesis. Thus, although the present experiments cannot rule out
this hypothesis, it does not seem to fulfil other criteria for an
activation process.
In contrast, the basis for the hypotheses in Fig. 7, B
D,
is that UCP1 activity is inhibited in the resting state because of the
effect of cytosolic purine nucleotides (ATP, ADP, GTP, and GDP
together); this point of view is based on the behavior of UCP1 in
isolated brown fat mitochondria (as reviewed in e.g. Refs.
6-9). In this case, an activator must therefore somehow overcome this inhibition.
According to one group of hypotheses (Fig. 7B),
norepinephrine generates an activator of UCP1 independent of its action
on hormone-sensitive lipase (e.g. cytosolic alkanization).
This activator then overcomes the purine nucleotide inhibition.
Considering the data presented here, that stimulation by added
fatty acids is UCP1-dependent, the postulation of a
further, nonlipolysis-related, activator would seem unnecessarily complex.
Alternatively, the intracellular physiological activator may be a
product of lipolysis. This could be the released free fatty acids
themselves (Fig. 7C). This is presently the prevalent
hypothesis for norepinephrine activation of thermogenesis (6, 48). The findings presented here do not in themselves contradict such a proposal, but this hypothesis is made less likely based on our studies
of isolated brown fat mitochondria, where we were unable to distinguish
a UCP1-dependent de-energization induced by free fatty
acids (15). As the de-energization observed in the isolated brown fat
mitochondria was UCP1-independent, it probably merely represented the
general uncoupling effect of fatty acids observed in any mitochondrial
preparation (37, 38), and the effect may therefore even be considered
artifactual. Therefore these mitochondrial observations make it
unlikely that fatty acids are the direct activators of UCP1 within the
cell; another activator would seem to be necessary. A hypothesis for an
activation scheme, based on the fact that fatty acids added to the
cells stimulate thermogenesis in a UCP1-dependent way (Fig.
5), is presented in D. However, it may be wondered why fatty
acids, that clearly function as UCP1-independent uncouplers in isolated
brown fat mitochondria (15), are unable to uncouple in an
UCP1-independent way when the same mitochondria are confined to cells.
A possibility is that the high levels of fatty acid-binding proteins
found in these cells (49) do not allow cytosolic free fatty acid levels
to become sufficiently high to reach the probably unphysiological levels necessary for UCP1-independent uncoupling of the mitochondria within the cells.
In view of the results presented here, that fatty acid uncoupling is
UCP1-dependent in cells in combination with the fact that
fatty acid in themselves were apparently unable to activate UCP1 in
isolated brown fat mitochondria (15), it would seem most plausible to
propose that the activation sequence in the cells involves adrenergic
stimulation of lipolysis and thus intracellular release of fatty acids.
However, it may be suggested that it is not the released fatty acids
themselves that activate UCP1 but rather a fatty acid metabolite (in a
broad sense) (Fig. 7D); this metabolite would be formed
irrespective of whether the fatty acids are of endogenous or exogenous
origin. The nature of such an activating metabolite is presently
unknown. However, one downstream product of fatty acid metabolism,
fatty acyl-CoA esters, can compete in isolated mitochondria with purine
nucleotides bound to UCP1 and increase ion transport through the
protein, i.e. activate UCP1 (50, 51), although no studies in
reconstituted systems have as yet confirmed these effects.
UCP2 and UCP3--
From cDNA libraries, mRNAs coding for
proteins now dubbed UCP2 (11, 12) and UCP3 (52, 53) were recently
identified. These mRNAs represent proteins more homologous to UCP1
than any other proteins presently identified. Because of this
relatively close homology, an evident initial suggestion was that these
proteins should also have thermogenesis/uncoupling as their function.
This suggestion gained initial support from experiments in which these proteins were ectopically expressed in yeast strains (11-14, 54-57) and in a myocyte cell line (58). In the yeast systems, ectopic expression of UCP2 or UCP3 led to poor growth, increased oxygen consumption, and to heat being released. A characteristic for these
systems with ectopic expression was also that a very high degree of
mitochondrial uncoupling was observed (i.e. a very much lowered mitochondrial membrane potential within the cells) and this has
been understood as being the reason for the poor growth of the
yeast strains.
Serendipitously, the present experiments may be helpful in establishing
whether these conclusions from experiments with ectopically expressed
UCP2/UCP3 are also valid when UCP2/UCP3 are entopically expressed. This
is because in the brown adipose tissue of the UCP1-ablated animals,
high expression levels of UCP2/UCP3 are found (10, 15, 16); UCP2
mRNA levels are even higher than those found in spleen and thus
represent the highest entopic level presently known, and UCP3 mRNA
levels are also very high. Thus, the combined entopic expression level
of UCP2 plus UCP3 is probably much higher than in any other tissue. It
is not directly demonstrated in any tissue as yet that high mRNA
levels of UCP2 or UCP3 are associated with high protein levels of these
proteins but there are indications that this is the case (59, 60). In
any case, all discussions so far on a metabolic effect of UCP2/UCP3
have tended to equate mRNA levels with protein levels. Therefore,
as very high UCP2/UCP3 mRNA levels are observed in the parent
tissue of these freshly isolated Ucp1(
/
)
brown adipocytes, the present study may indicate whether such high
expression levels are necessarily associated with a very high innate
uncoupling (as is the case in yeast) or with an inducible uncoupling.
It can be concluded unquestionably from the present study that the high
UCP2 and UCP3 expression in the tissue does not necessarily result in
an innate, overtly high level of respiration (uncoupling) in the
isolated cells prior to stimulation (Fig. 1) and that the mitochondria
within these cells seem to be at least as tightly coupled in the basal
state as those in the wild-type cells (Fig. 2). That a small fraction
of this, in itself, very low proton permeability could be
UCP2/UCP3-dependent can, of course, not be excluded but
considering the very high expression level for UCP2/UCP3 occurring
here, this would mean that the effect of normal levels of UCP2/UCP3
would be technically undetectable.
These results thus extend conclusions from recent studies of isolated
mitochondria from brown adipose tissue. In such preparations, we (15)
and others (61) could find no indication that high tissue expression
levels of UCP2/UCP3 resulted in innate uncoupling of isolated
mitochondria from that tissue. A similar conclusion was also reached
with muscle mitochondria (60). However, it could be surmised in all
those studies that the absence of uncoupling could be because of the
artificial situation of isolated mitochondria, viz. that an
important intracellular activator was lost during mitochondrial
isolation. It is, however, the implication from the present experiments
that even in a natural cellular environment, high expression of
UCP2/UCP3 in a tissue is not associated with a detectable thermogenic
rate in the cells of that tissue.
Added fatty acids (oleate or laurate), retinoate, or the retinoate
analogue TTNPB also failed to induce thermogenesis in the Ucp1(
/
) cells. This is notable because it has
been observed in isolated reconstituted systems that UCP2 and UCP3,
perhaps similarly to certain other mitochondrial translocators, can
function as fatty acid transporters (17). According to the
Skulachev/Garlid fatty acid cycling model, this is the mechanism of
heat production for both UCP1, UCP2, and UCP3 (17, 62). Retinoic acid
and, with even higher affinity, TTNPB, has also been demonstrated to activate UCP2 in mitochondria where it has been ectopically expressed (40). However, it is clear that the mere provision of levels of oleate,
laurate, or retinoate, sufficiently high to activate UCP1 under the
same conditions (i.e. in the wild-type cells) did not lead
to activation of a thermogenic function in
Ucp1(
/
) cells. Further, even when fatty acids
were provided endogenously by norepinephrine-induced lipolysis, they
were still unable to activate any thermogenic response in the
Ucp1(
/
) cells. Indeed, the absence of
response to norepinephrine indicates that no intracellular activator of
a thermogenic response via UCP2/UCP3 or any other protein can be
induced in these cells via sympathetic stimulation, irrespective of the
nature of such an activator.
Consequently, it is clear that despite the very high expression levels
of novel UCPs found in the parent tissue of the
Ucp1(
/
) cells, we made no observation
supporting a hypothetical role of these UCPs as potent uncoupling
proteins, either under basal conditions or following norepinephrine or
fatty acid stimulation. This could be indicating that the proteins are
not synthesized in the cells, despite their high expression levels at
the mRNA level; alternatively, some other as yet unidentified
mechanism could lead to the activation of these proteins or they could
be associated with an extremely small degree of innate uncoupling not
discernable under our experimental conditions. However, despite the
high expression levels, the cells seem incapable of classical
sympathetically mediated nonshivering thermogenesis, an observation
principally in keeping with the fact that the animals are acutely
highly cold-sensitive (10, 16) and thus do not demonstrate any
significant compensation mechanism for the loss of UCP1.
Conclusions--
Although UCP1, UCP2, and UCP3 have all been shown
to possess an uncoupling action when ectopically expressed, it is the
conclusion of the present investigation that in brown adipose tissue
UCP1 is the only one of these "uncoupling proteins" that is
physiologically thermogenic, i.e. when entopically expressed
is able to endow cells with a physiologically relevant,
adrenergically induced thermogenic capacity. In this way, UCP1
("thermogenin") thus clearly distinguishes itself from the novel
uncoupling proteins which, as yet, have not been shown to be associated
with any physiological thermogenesis.
 |
ACKNOWLEDGEMENTS |
We are grateful to Leslie P. Kozak for
valuable contributions and to Lars Ottosson for mitochondrial control experiments.
 |
FOOTNOTES |
*
This work was supported by a grant (to B. C. and
J. N.) and a postdoctoral fellowship (to A. M.) from the
Swedish Natural Science Research Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Dept. of Medicine, University of Queensland,
Royal Brisbane Hospital, Herston, QLD 4029, Australia.
§
To whom correspondence should be addressed: The
Wenner-Gren Institute, The Arrhenius Laboratories F3, Stockholm
University, SE-106 91 Stockholm, Sweden. Tel.: 46 8 164120; Fax: 46 8 156756; E-mail: barbara.cannon@wgi.su.se.
Published, JBC Papers in Press, May 23, 2000, DOI 10.1074/jbc.M000547200
2
V. Golozoubova, B. Cannon, and J. Nedergaard,
unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
UCP, uncoupling
protein;
FCCP, carbonyl cyanide
p-trifluoromethoxyphenylhydrazone.
 |
REFERENCES |
| 1.
|
Prusiner, S. B.,
Cannon, B.,
and Lindberg, O.
(1968)
Eur. J. Biochem.
6,
15-22
|
| 2.
|
Reed, N.,
and Fain, J. N.
(1968)
J. Biol. Chem.
243,
2843-2848
|
| 3.
|
Nedergaard, J.,
Cannon, B.,
and Lindberg, O.
(1977)
Nature
267,
518-520
|
| 4.
|
Nedergaard, J.,
and Lindberg, O.
(1982)
Int. Rev. Cytol.
74,
187-286
|
| 5.
|
Smith, R. E.
(1961)
Physiologist
4,
113
|
| 6.
|
Nicholls, D. G.,
and Locke, R. M.
(1984)
Physiol. Rev.
64,
1-64
|
| 7.
|
Nedergaard, J.,
and Cannon, B.
(1992)
in
New Comprehensive Biochemistry
(Ernster, L., ed), Vol. 23
, pp. 385-420, Elsevier, Amsterdam
|
| 8.
|
Garlid, K. D.,
Jaburek, M.,
and Jezek, P.
(1998)
FEBS Lett.
438,
10-14
|
| 9.
|
Klingenberg, M.,
and Huang, S. G.
(1999)
Biochim. Biophys. Acta
1415,
271-296
|
| 10.
|
Enerbäck, S.,
Jacobsson, A.,
Simpson, E. M.,
Guerra, C.,
Yamashita, H.,
Harper, M.-E.,
and Kozak, L. P.
(1997)
Nature
387,
90-94
|
| 11.
|
Fleury, C.,
Neverova, M.,
Collins, S.,
Raimbault, S.,
Champigny, O.,
Levi-Meyrueis, C.,
Bouillaud, F.,
Seldin, M. F.,
Surwit, R. S.,
Ricquier, D.,
and Warden, C. H.
(1997)
Nat. Genet.
15,
269-272
|
| 12.
|
Gimeno, R. E.,
Dembski, M.,
Weng, X.,
Deng, N.,
Shyjan, A. W.,
Gimeno, C. J.,
Iris, F.,
Ellis, S. J.,
Woolf, E. A.,
and Tartaglia, L. A.
(1997)
Diabetes
46,
900-906
|
| 13.
|
Hagen, T.,
Zhang, C.-Y.,
Slieker, L. J.,
Chung, W. K.,
Leibel, R. L.,
and Lowell, B. B.
(1999)
FEBS Lett.
454,
201-206
|
| 14.
|
Zhang, C.-Y.,
Hagen, T.,
Mootha, V. K.,
Slieker, L. J.,
and Lowell, B. B.
(1999)
FEBS Lett.
449,
129-134
|
| 15.
|
Matthias, A.,
Jacobsson, A.,
Cannon, B.,
and Nedergaard, J.
(1999)
J. Biol. Chem.
274,
28150-28160
|
| 16.
|
Cannon, B.,
Matthias, A.,
Golozoubova, V.,
Ohlson, K. B. E.,
Andersson, U.,
Jacobsson, A.,
and Nedergaard, J.
(1999)
in
Progress in Obesity Research 8
(Ailhaud, G.
, and Guy-Grand, B., eds)
, pp. 13-26, John Libbey, London
|
| 17.
|
Jaburek, M.,
Varecha, M.,
Gimeno, R. E.,
Dembski, M.,
Jezek, P.,
Zhang, M.,
Burn, P.,
Tartaglia, L. A.,
and Garlid, K. D.
(1999)
J. Biol. Chem.
274,
26003-26007
|
| 18.
|
Stuart, J. A.,
Harper, J. A.,
Brindle, K. M.,
and Brand, M. D.
(1999)
Biochim. Biophys. Acta
1413,
50-54
|
| 19.
|
Zhao, J.,
Cannon, B.,
and Nedergaard, J.
(1998)
Can. J. Physiol. Pharmacol.
76,
428-433
|
| 20.
|
Ohlson, K. B. E.,
Mohell, N.,
Cannon, B.,
Lindahl, S. G. E.,
and Nedergaard, J.
(1994)
Anesthesiology
81,
176-183
|
| 21.
|
Mohell, N.,
Nedergaard, J.,
and Cannon, B.
(1983)
Eur. J. Pharmacol.
93,
183-193
|
| 22.
|
Chappell, J. B.,
and Crofts, A. R.
(1965)
Biochem. J.
95,
378-386
|
| 23.
|
Bukowiecki, L.,
Follea, N.,
Paradis, A.,
and Collet, A.
(1980)
Am. J. Physiol.
238,
E552-E563
|
| 24.
|
Locke, R. M.,
Rial, E.,
and Nicholls, D. G.
(1982)
Eur. J. Biochem.
129,
381-387
|
| 25.
|
Nedergaard, J.,
and Lindberg, O.
(1979)
Eur. J. Biochem.
95,
139-145
|
| 26.
|
Prusiner, S. B.,
Cannon, B.,
Ching, T. M.,
and Lindberg, O.
(1968)
Eur. J. Biochem.
7,
51-57
|
| 27.
|
Bernson, V.,
Lundberg, P.,
and Pettersson, B.
(1979)
Biochim. Biophys. Acta
587,
353-361
|
| 28.
|
Rafael, J.,
Fesser, W.,
and Nicholls, D.
(1986)
Am. J. Physiol.
250,
C228-C235
|
| 29.
|
Sundin, U.,
Moore, G.,
Nedergaard, J.,
and Cannon, B.
(1987)
Am. J. Physiol.
252,
R822-R832
|
| 30.
|
Zhao, J.,
Cannon, B.,
and Nedergaard, J.
(1997)
J. Biol. Chem.
272,
32847-32856
|
| 31.
|
Zhao, J.,
Cannon, B.,
and Nedergaard, J.
(1998)
Am. J. Physiol.
275,
R2002-R2011
|
| 32.
|
Unelius, L.,
Bronnikov, G.,
Mohell, N.,
and Nedergaard, J.
(1993)
Am. J. Physiol.
265,
C1340-C1348
|
| 33.
|
Holm, C.,
Fredrikson, G.,
Cannon, B.,
and Belfrage, P.
(1987)
Biosci. Rep.
7,
897-904
|
| 34.
|
Reed, N.,
and Fain, J. N.
(1968)
J. Biol. Chem.
243,
6077-6083
|
| 35.
|
Cunningham, S. A.,
Wiesinger, H.,
and Nicholls, D. G.
(1986)
Eur. J. Biochem.
157,
415-420
|
| 36.
|
Bukowiecki, L. J.,
Follea, N.,
Lupien, J.,
and Paradis, A.
(1981)
J. Biol. Chem.
256,
12840-12848
|
| 37.
|
Wojtczak, L.,
and Schönfeld, P.
(1993)
Biochim. Biophys. Acta
1183,
41-57
|
| 38.
|
Skulachev, V. P.
(1998)
Biochim. Biophys. Acta
1363,
100-124
|
| 39.
|
Soboll, S.,
and Stucki, J.
(1985)
Biochim. Biophys. Acta
807,
245-254
|
| 40.
|
Rial, E.,
Gonzalez-Barroso, M.,
Fleury, C.,
Iturrizaga, S.,
Sanchis, D.,
Jimenez-Jimenez, J.,
Ricquier, D.,
Goubern, M.,
and Bouillaud, F.
(1999)
EMBO J.
18,
5827-5833
|
| 41.
|
Li, B.,
Holloszy, J. O.,
and Semenkovich, C. F.
(1999)
J. Biol. Chem.
274,
17534-17540
|
| 42.
|
Bathgate, B.,
Freebairn, E. M.,
Greenland, A. J.,
and Reid, G. A.
(1992)
Mol. Microbiol.
6,
363-370
|
| 43.
|
Bouillaud, F.,
Arechaga, I.,
Petit, P. X.,
Raimbault, S.,
Levi-Meyrueis, C.,
Casteilla, L.,
Laurent, M.,
Rial, E.,
and Ricquier, D.
(1994)
EMBO J.
13,
1990-1997
|
| 44.
|
Gonzalez-Barroso, M. M.,
Fleury, C.,
Arechaga, I.,
Zaragoza, P.,
Levi-Meyrueis, C.,
Raimbault, S.,
Ricquier, D.,
Bouillaud, F.,
and Rial, E.
(1996)
Eur. J. Biochem.
239,
445-450
|
| 45.
|
Sundin, U.,
and Cannon, B.
(1980)
Comp. Biochem. Physiol.
65B,
463-471
|
| 46.
|
Rafael, J.,
Pampel, I.,
and Wang, X.
(1994)
Eur. J. Biochem.
223,
971-980
|
| 47.
|
Brooks, S. P. J.,
and Storey, K. B.
(1992)
Anal. Biochem.
201,
119-126
|
| 48.
|
Gonzalez-Barroso, M. M.,
Fleury, C.,
Bouillaud, F.,
Nicholls, D. G.,
and Rial, E.
(1998)
J. Biol. Chem.
273,
15528-15532
|
| 49.
|
Daikoku, T.,
Shinohara, Y.,
Shima, A.,
Yamazaki, N.,
and Terada, H.
(1997)
FEBS Lett.
410,
383-386
|
| 50.
|
Cannon, B.,
Sundin, U.,
and Romert, L.
(1977)
FEBS Lett.
74,
43-46
|
| 51.
|
Katiyar, S. S.,
and Shrago, E.
(1991)
Biochem. Biophys. Res. Commun.
175,
1104-1111
|
| 52.
|
Boss, O.,
Samec, S.,
Paoloni-Giacobino, A.,
Rossier, C.,
Dulloo, A.,
Seydoux, J.,
Muzzin, P.,
and Giacobino, J. P.
(1997)
FEBS Lett.
408,
39-42
|
| 53.
|
Vidal-Puig, A.,
Solanes, G.,
Grujic, D.,
Flier, J. S.,
and Lowell, B. B.
(1997)
Biochem. Biophys. Res. Commun.
235,
79-82
|
| 54.
|
Gong, D. W.,
He, Y.,
Karas, M.,
and Reitman, M.
(1997)
J. Biol. Chem.
272,
24129-24132
|
| 55.
|
Liu, Q.,
Bai, C.,
Chen, F.,
Wang, R.,
MacDonald, T.,
Gu, M.,
Zhang, Q.,
Morsy, M. A.,
and Caskey, C. T.
(1998)
Gene (Amst.)
207,
1-7
|
| 56.
|
Paulik, M. A.,
Buckholz, R. G.,
Lancaster, M. E.,
Dallas, W. S.,
Hull-Ryde, E. A.,
Weiel, J. E.,
and Lenhard, J. M.
(1998)
Pharm. Res. (N. Y.)
15,
944-949
|
| 57.
|
Hinz, W.,
Faller, B.,
Gruninger, S.,
Gazzotti, P.,
and Chiesi, M.
(1999)
FEBS Lett.
448,
57-61
|
| 58.
|
Boss, O.,
Samec, S.,
Kuhne, F.,
Bijlenga, P.,
Assimacopoulos-Jeannet, F.,
Seydoux, J.,
Giacobino, J. P.,
and Muzzin, P.
(1998)
J. Biol. Chem.
273,
5-8
|
| 59.
|
Jezek, P.,
Zackova, M.,
Rehakova, Z.,
Ruzicka, M.,
Borecky, J.,
Skobisova, E.,
Brucknerova, J.,
Garlid, K. D.,
Gimeno, R. E.,
and Tartaglia, L. A.
(1999)
FEBS Lett.
455,
79-82
|
| 60.
|
Cadenas, S.,
Buckingham, J. A.,
Samec, S.,
Seydoux, J.,
Din, N.,
Dulloo, A. G.,
and Brand, M. D.
(1999)
FEBS Lett.
462,
257-260
|
| 61.
|
Monemdjou, S.,
Kozak, L. P.,
and Harper, M. E.
(1999)
Am. J. Physiol.
276,
E1073-E1082
|
| 62.
|
Jezek, P.,
Engstova, H.,
Zackova, M.,
Vercesi, A. E.,
Costa, A. D.,
Arruda, P.,
and Garlid, K. D.
(1998)
Biochim. Biophys. Acta
1365,
319-327
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
